“Determination of the smallest detectable change (SDC) and the minimal important difference (MID) for the Small Fiber Neuropathy Screening List (SFNSL) in sarcoidosis: Interpretability of the SFNSL” (2018) Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 35(4), pp. 333–341. doi:10.36141/svdld.v35i4.7260.